Pepscan appoints new chief business officer
This article was originally published in Scrip
Executive Summary
Pepscan Therapeutics, a Dutch biotech company focusing on protein mimicry for the discovery of therapeutics peptides and antibodies, has appointed Dr Michiel Lodder chief business officer. He joins from Octoplus, where he served as senior manager business development, responsible for licensing, partnering and alliance management activities.